Lao version of osimertinib (osimertinib) generic drug use guide

Osimertinib, trade name Tagrisso, is a third-generation targeted drug for non-small cell lung cancer (NSCLC), especially patients with EGFR mutation-positive patients. It effectively inhibits the growth and spread of tumor cells by specifically inhibiting the activity of EGFR mutant proteins, providing a new treatment option for many lung cancer patients. However, due to their high R&D costs and patent protection, the price of original drugs often prohibits many patients. Fortunately, generic drugs of osimertinib produced by Lao Lucius, Lao United Pharmaceuticals and Lao ASEAN Pharmaceuticals are very popular in the market at more affordable prices.

For the use of the Lao version of the generic version of osimertinib, patients need to follow certain guidelines. First of all, the drug is recommended to be taken orally once a day, 80 mg each time. The taking time is not affected by food and can be taken with food or alone. If the patient has difficulty swallowing the entire tablet, the patient can place the tablet in a glass with approximately 60 ml of water, being careful to avoid carbonated water or other liquids. Stir gently until tablets break into small pieces, but do not have to be completely dissolved. Do not crush, heat or microwave. Immediately drink the mixture, add 120 to 240 ml of water to the cup, shake gently and drink quickly to ensure the full dose of osimertinib is taken.

If you accidentally miss a dose, there is no need to take it again. Just continue taking the next dose as planned. In terms of storage, it is recommended to store osimertinib at room temperature between 68°F and 77°F (i.e. 20°C and 25°C), avoiding high temperatures or humid environments.

The Lao version of osimertinib generic drug is not only affordable, but also has guaranteed quality, providing patients with a new treatment option. However, during use, patients still need to follow medical instructions and pay attention to the correct taking method and storage conditions of the drug to ensure therapeutic effect and safety. At the same time, regular communication with doctors about changes in condition and timely adjustment of treatment plans are the keys to ensuring treatment effects.